Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ProShares Trust ProShares Short Bitcoin Strategy ETF
(ARCA:BITI)
Intraday
$8.00
-0.14
[-1.72%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$8.00
-0.14
[-1.72%]
Last update: 9:29AM
Get Real Time Here
Get Report
Watch
Overview
News
Dividends
Short Interest
Latest News for ProShares Trust ProShares Short Bitcoin Strategy ETF (ARCA:BITI)
ProShares Trust ProShares Short Bitcoin Strategy ETF (ARCA: BITI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, August 30, 2022
Think Bitcoin Will Go Down? New ETF Bets Against Bitcoin Bull Michael Saylor And MicroStrategy
Chris Katje
-
Aug 30, 2022, 6:23PM
Sunday, August 28, 2022
Exposure To Crypto: Exploring Passive Investment Opportunities Using Bitcoin ETFs
Murtuza Merchant
-
Aug 28, 2022, 11:21AM
Wednesday, July 06, 2022
Bitcoin, Ethereum, Dogecoin Shrug Off Hawkish Fed, Voyager Crisis: Analysts Pencil Apex Coin's Next Breakout Range
Shivdeep Dhaliwal
-
Jul 6, 2022, 9:24PM
Tuesday, July 05, 2022
'Short-Bitcoin' Funds See Record $51M Inflows In A Week
Samyuktha Sriram
-
Jul 5, 2022, 6:03AM
Monday, June 27, 2022
Bitcoin Funds Saw Over $450M Weekly Outflows As Price Fell To $17,760
Samyuktha Sriram
-
Jun 27, 2022, 2:26PM
Thursday, June 23, 2022
Coffee And Crypto: The First Short Bitcoin ETF Has Arrived
AJ Fabino
-
Jun 23, 2022, 10:09AM
Wednesday, June 22, 2022
Top News In Fintech And Beyond For June 23, 2022
Renato Capelj
-
Jun 22, 2022, 8:52PM
Monday, June 20, 2022
Want To Short The Price Of Bitcoin? There's A New ETF That Can Help
Chris Katje
-
Jun 20, 2022, 4:30PM
Wednesday, May 18, 2016
Biotie Therapies Cancels All Treasury Shares Held by Company
Benzinga
-
May 18, 2016, 4:26AM
Biotie Therapies to Delist ADS from Nasdaq Global Select Market
Benzinga
-
May 18, 2016, 4:16AM
Monday, April 25, 2016
Acorda Reports 93.9% Stake in Biotie Therapies in 13D
Benzinga
-
Apr 25, 2016, 4:40PM
Wednesday, April 13, 2016
Accorda Therapeutics Announces Final Results Of Tender Offer On Biotie Therapies
Benzinga
-
Apr 13, 2016, 10:14AM
Tuesday, April 12, 2016
Roth Capital Terminates Neutral Rating on Biotie Therapies, Removes $26.00 PT
Benzinga
-
Apr 12, 2016, 6:00AM
Monday, March 21, 2016
RBC Capital Downgrades Biotie Therapies to Sector Perform, Lowers PT to $25.60
Benzinga
-
Mar 21, 2016, 7:20AM
Thursday, March 03, 2016
Acorda Files Tender Offer Document Relating to Public Tender Offer for Biotie Therapies with Finnish Financial Supervisory Authority
Benzinga
-
Mar 3, 2016, 4:31AM
Friday, February 12, 2016
13F Shows Baupost Group Increases Stake In Biotie Therapies
Benzinga
-
Feb 12, 2016, 4:54PM
Tuesday, February 09, 2016
10 Stocks Moving In Tuesday's Pre-Market Session
Benzinga
-
Feb 9, 2016, 8:19AM
Tuesday, January 19, 2016
Benzinga's M&A Chatter for Tuesday January 19, 2015
Benzinga
-
Jan 19, 2016, 9:26PM
Mid-Afternoon Market Update: US Stocks Turn Red; Crude Oil Falls Over 3%
Benzinga
-
Jan 19, 2016, 2:48PM
Mid-Day Market Update: Dow Surges 150 Points; Progressive Waste Shares Spike Higher
Benzinga
-
Jan 19, 2016, 12:21PM
Mid-Morning Market Update: Markets Open Higher; Bank of America Earnings Top Views
Benzinga
-
Jan 19, 2016, 10:05AM
Acorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development
Benzinga
-
Jan 19, 2016, 9:40AM
Acorda to Acquire Biotie Therapies for $25.60/ADS
Benzinga
-
Jan 19, 2016, 4:15AM
Tuesday, July 07, 2015
Roth Puts A 'Buy' On Biotie...Firm Excited About 'Best In Class Treatment' For Parkinson's
Benzinga
-
Jul 7, 2015, 9:08AM
Roth Capital Initiates Coverage on Biotie Therapies at Buy, Announces $26.00 PT
Benzinga
-
Jul 7, 2015, 7:21AM
Monday, July 06, 2015
New Wall Street Coverage: GoPro, Kraft Heinz And More
Benzinga
-
Jul 6, 2015, 3:03PM
Stifel Starts Biotie At Buy, Says Lead Product Can 'Meaningfully Improve' Parkinson's Patients
Benzinga
-
Jul 6, 2015, 11:21AM
Benzinga's Top Initiations
Benzinga
-
Jul 6, 2015, 9:57AM
Stifel Nicolaus Initiates Biotie Therapies At Buy
Benzinga
-
Jul 6, 2015, 9:34AM
JMP Securities Initiates Coverage on Biotie Therapies at Outperform, Announces $32.00 PT
Benzinga
-
Jul 6, 2015, 7:55AM
Stifel Nicolaus Initiates Coverage on Biotie Therapies at Buy, Announces $30.00 PT
Benzinga
-
Jul 6, 2015, 7:17AM
Stifel Nicolaus Initiates Coverage on Biotie Therapies at Buy, Announces $30.00 PT
Benzinga
-
Jul 6, 2015, 6:47AM
RBC Capital Initiates Coverage on Biotie Therapies at Outperform, Announces $35.00 PT
Benzinga
-
Jul 6, 2015, 6:46AM
Monday, June 22, 2015
Morning Market Losers
Benzinga
-
Jun 22, 2015, 9:49AM
Benzinga's Top #PreMarket Losers
Benzinga
-
Jun 22, 2015, 8:19AM
Thursday, June 11, 2015
Biotie Therapies Surging Following IPO Debut
Benzinga
-
Jun 11, 2015, 4:18PM
Shares of BioTie Therapeutics Shares Open for Trade at $16.25, IPO Priced at $14.88/ADS
Benzinga
-
Jun 11, 2015, 10:52AM
Wednesday, June 10, 2015
Biotie Therapies Making Strides In Neurodegenerative Diseases
Benzinga
-
Jun 10, 2015, 12:50PM
Tuesday, June 09, 2015
IPO Outlook: Wingstop's 'Atomic' IPO To Top New Issues This Week
Benzinga
-
Jun 9, 2015, 11:32AM